Popular weight loss drugs linked to unexpected male fertility benefit GLP-1 drugs like semaglutide and liraglutide do not appear to suppress male hormones and may boost fertility in obese men, new research suggests.
Weight-loss drugs linked to 'Ozempic ears' and other cosmetic complaints, surgeons say GLP-1 weight loss drugs like Ozempic are linked to cosmetic concerns, including sagging earlobes, deflated breasts and flatter buttocks, surgeons say.
Ozempic users may be making a major weight-loss mistake, new study suggests New research finds GLP-1 users significantly reduced physical activity, with daily steps and exercise declining after starting a weight loss medication.
Secret to weight loss may be hiding in your gut, new study suggests New scientific research finds that a pasteurized gut bacterium may help prevent weight regain after dieting, with promising study results.
Expert says 'black and gray' peptide market is reshaping fitness culture Dr. Alex Tatem explains how restrictions on certain compounds can drive consumers toward social media advice, uncertain sourcing and dosing questions that may put them at risk.
Ozempic-style drugs linked to major slowdown in cancer spread, new study finds A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers, including lung cancer.
5 common walking mistakes that could hurt your progress, according to an expert Walking has many proven health benefits, but common mistakes like scrolling and wearing the wrong shoes could cause more harm than good, expert says.
‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access The peptide market is surging alongside GLP-1 demand, creating tension between compounding pharmacies and commercial drug companies over patient access.
New obesity treatment may help preserve muscle during weight loss Gwyneth Paltrow and neuroscientist Andrew Huberman explore retatrutide, a new triple-agonist GLP-1 therapy said to reduce side effects and spare muscle.
Experimental obesity drug outperforms traditional weight-loss treatments in early research An experimental weight loss drug tested in mice targets five receptor systems and may reduce side effects, according to a study published in Nature.